Acadian Asset Management LLC Boosts Stock Holdings in Bausch Health Cos Inc. $BHC

Key Points

• Acadian Asset Management LLC significantly increased its stake in Bausch Health Cos Inc. by 4,134.7%, acquiring over 657,416 additional shares and now owning a total of 673,316 shares valued at approximately $4.35 million.
• Bausch Health reported earnings per share of $0.90 for the last quarter, falling short of analysts' expectations, though its revenue was higher than estimates at $2.57 billion.
• Director John Paulson made a substantial purchase of 34.7 million shares, increasing his ownership in Bausch Health by 96.35% and reflecting a strong confidence in the company's future.

Acadian Asset Management LLC increased its position in shares of Bausch Health Cos Inc. (NYSE:BHC - Free Report) by 4,134.7% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 673,316 shares of the company's stock after purchasing an additional 657,416 shares during the period. Acadian Asset Management LLC owned 0.19% of Bausch Health Cos worth $4,347,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Toronto Dominion Bank grew its stake in shares of Bausch Health Cos by 1.0% during the fourth quarter. Toronto Dominion Bank now owns 167,212 shares of the company's stock worth $1,350,000 after purchasing an additional 1,712 shares in the last quarter. SBI Securities Co. Ltd. grew its stake in shares of Bausch Health Cos by 244.2% during the first quarter. SBI Securities Co. Ltd. now owns 4,230 shares of the company's stock worth $27,000 after purchasing an additional 3,001 shares in the last quarter. Cary Street Partners Financial LLC acquired a new position in shares of Bausch Health Cos during the first quarter worth $27,000. Caitong International Asset Management Co. Ltd acquired a new position in shares of Bausch Health Cos during the first quarter worth $27,000. Finally, Viewpoint Capital Management LLC grew its stake in shares of Bausch Health Cos by 27.0% during the first quarter. Viewpoint Capital Management LLC now owns 24,000 shares of the company's stock worth $155,000 after purchasing an additional 5,100 shares in the last quarter. Institutional investors and hedge funds own 78.65% of the company's stock.

Bausch Health Cos Price Performance

Shares of BHC opened at $7.27 on Monday. Bausch Health Cos Inc. has a fifty-two week low of $4.25 and a fifty-two week high of $9.85. The company has a market capitalization of $2.69 billion, a price-to-earnings ratio of 27.96 and a beta of 0.48. The firm has a 50-day simple moving average of $6.87 and a 200-day simple moving average of $6.08. The company has a debt-to-equity ratio of 141.90, a quick ratio of 0.98 and a current ratio of 1.31.

Bausch Health Cos (NYSE:BHC - Get Free Report) last announced its earnings results on Wednesday, July 30th. The company reported $0.90 earnings per share for the quarter, missing the consensus estimate of $0.97 by ($0.07). Bausch Health Cos had a negative return on equity of 852.36% and a net margin of 0.99%.The business had revenue of $2.57 billion for the quarter, compared to analyst estimates of $2.47 billion. Bausch Health Cos has set its FY 2025 guidance at EPS. On average, equities research analysts anticipate that Bausch Health Cos Inc. will post 4.41 earnings per share for the current year.

Analyst Ratings Changes

Separately, Wall Street Zen upgraded shares of Bausch Health Cos from a "hold" rating to a "buy" rating in a research note on Saturday, August 2nd. Three equities research analysts have rated the stock with a Hold rating, According to MarketBeat, Bausch Health Cos has a consensus rating of "Hold" and an average price target of $9.00.

Insider Buying and Selling at Bausch Health Cos

In other news, Director John Paulson acquired 34,721,118 shares of Bausch Health Cos stock in a transaction that occurred on Thursday, August 14th. The stock was purchased at an average price of $9.00 per share, for a total transaction of $312,490,062.00. Following the completion of the transaction, the director directly owned 70,755,869 shares in the company, valued at approximately $636,802,821. This trade represents a 96.35% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders have bought a total of 37,964,167 shares of company stock worth $333,757,793 in the last three months. 19.97% of the stock is currently owned by corporate insiders.

Bausch Health Cos Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.